When treated with these drugs approximately 50–75% of patients with acromegaly achieve biochemical control, defined as GH <2.5 μg/L and normal age- and sex-adjusted insulin-like growth factor-I (IGF-I) levels [4], [5]. This evidence concerns the gene GH1 and acromegaly.